Apadenoson
- Generic Name
- Apadenoson
- Drug Type
- Small Molecule
- Chemical Formula
- C23H30N6O6
- CAS Number
- 250386-15-3
- Unique Ingredient Identifier
- BTS1Y6777M
Overview
Apadenoson is a selective A2a adenosine receptor agonist designed for use as a pharmacologic stress agent in cardiac perfusion imaging studies. It is developed by Bristol-Myers Squibb and is in phase II of clinical trials.
Background
Apadenoson is a selective A2a adenosine receptor agonist designed for use as a pharmacologic stress agent in cardiac perfusion imaging studies. It is developed by Bristol-Myers Squibb and is in phase II of clinical trials.
Indication
Investigated for use/treatment in cardiovascular disorders and inflammatory disorders (unspecified).
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath